Comment: Lessons from the clinic: A case of natalizumab-associated PML

David B. Clifford

doi:10.1212/WNL.0b013e31820b35d7

Comment: Lessons from the clinic: A case of natalizumab-associated PML

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	574
Number of pages	1
Journal	Neurology
Volume	76
Issue number	6
DOIs	https://doi.org/10.1212/WNL.0b013e31820b35d7
State	Published - Feb 8 2011

Access to Document

10.1212/WNL.0b013e31820b35d7

Cite this

@article{4d6f0e250acd4a4e9c0c75c8466f5a4b,

title = "Comment: Lessons from the clinic: A case of natalizumab-associated PML",

author = "Clifford, {David B.}",

note = "Funding Information: Disclosure: Dr. Clifford serves/has served on scientific advisory boards for Biogen Idec, Elan Corporation, Roche, Forest Laboratories, Inc., Genentech, Inc., GlaxoSmithKline, Millennium Pharmaceuticals, Inc., Schering-Plough Corp., Bristol-Meyers Squibb, and Genzyme Corporation; received speaker honoraria and funding for travel from GlaxoSmithKline, Millennium Pharmaceuticals, Inc., and Genentech Inc.; has received research support from Pfizer Inc., Schering-Plough Corp., Bavarian Nordic, NeurogesX, GlaxoSmithKline, Tibotec Therapeutics, Boehringer Ingelheim, and Gilead Sciences, Inc.; and receives research support from the NIH (NIMH, NIDA). ",

year = "2011",

month = feb,

day = "8",

doi = "10.1212/WNL.0b013e31820b35d7",

language = "English",

volume = "76",

pages = "574",

journal = "Neurology",

issn = "0028-3878",

number = "6",

}

TY - JOUR

T1 - Comment

T2 - Lessons from the clinic: A case of natalizumab-associated PML

AU - Clifford, David B.

N1 - Funding Information: Disclosure: Dr. Clifford serves/has served on scientific advisory boards for Biogen Idec, Elan Corporation, Roche, Forest Laboratories, Inc., Genentech, Inc., GlaxoSmithKline, Millennium Pharmaceuticals, Inc., Schering-Plough Corp., Bristol-Meyers Squibb, and Genzyme Corporation; received speaker honoraria and funding for travel from GlaxoSmithKline, Millennium Pharmaceuticals, Inc., and Genentech Inc.; has received research support from Pfizer Inc., Schering-Plough Corp., Bavarian Nordic, NeurogesX, GlaxoSmithKline, Tibotec Therapeutics, Boehringer Ingelheim, and Gilead Sciences, Inc.; and receives research support from the NIH (NIMH, NIDA).

PY - 2011/2/8

Y1 - 2011/2/8

UR - http://www.scopus.com/inward/record.url?scp=79951659640&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31820b35d7

DO - 10.1212/WNL.0b013e31820b35d7

M3 - Article

C2 - 21300972

AN - SCOPUS:79951659640

SN - 0028-3878

VL - 76

SP - 574

JO - Neurology

JF - Neurology

IS - 6

ER -

Comment: Lessons from the clinic: A case of natalizumab-associated PML

Access to Document

Other files and links

Cite this